logo-loader

Collagen bolsters patent protection in Australia

Published: 09:02 29 Mar 2017 BST

heart symbol
Australia is a major source of pericardium-based tissues

Collagen Solutions PLC (LON:COS) has been granted additional patent protecttion in Australia for the ultra-thin processed pericardium tissue for heart valve replacement and other uses.

New Zealand and Australia are the first choice for animal-based biomaterials, said Collagen, and the countries have been supplying material under strict controls for decades.

WATCH: Collagen boss hails additional patent ...

The divisional patent will allow Collagen to source materials from within Australia and also protect its proprietary knowledge in the supply and development of pericardium-based tissues.

Jamal Rushdy, chief executive, said: "Our pericardium tissue business has been growing and has promising potential in cardiovascular and other markets including general surgery, orthopaedics, wounds, and dental.

“This recent patent further strengthens our position in sourcing tissue in Australia in a novel way. 

“We believe the additional processing covered in this patent will be of significant interest to our existing customer base".

Morning Report: Vaccines and EU package lift FTSE 100

Headlines from the Proactive UK newsroom. The FTSE 100 was in better heart as yesterday’s vaccine news and €750bn EU bail-out package helped sentiment. The blue-chip index rose 43 points to 6,305. Grocery tills were their busiest ever over the past 12 weeks according to market research...

on 21/7/20